Smart rings, CGMs, biosensor patches, remote patient monitoring, and the reimbursement rules that govern them.
University of Chicago researchers unveiled a flexible computing patch that processes cardiac data directly on the body, eliminating the cloud latency that can prove fatal in cardiac events.
Seventeen codes would become four. Third-party monitoring vendors would be shut out. The CY2027 proposed rule responds to OIG fraud findings — and would rewire the business model of an entire industry.
The industry-leading 15.5-day wear time cuts per-day cost and sensor changes for Canada's 4 million people living with diabetes — and sharpens the competitive edge against Abbott's FreeStyle Libre.
The smallest Oura yet ships with background cardiovascular and breathing monitoring, GLP-1 medication insights, and virtual consults in 43 states — and July's software rollout brought key features to Gen 3 and Gen 4 rings.
Led by Khosla Ventures — with angels including Anne Wojcicki — the Stanford-founded startup packs 10 biosensors into a wrist wearable targeting perimenopause, cycle irregularity, and the gaps period-tracking apps can't reach.
The June rollout turns the watch into what Samsung calls an 'AI-powered everyday health companion' — benchmarking five overnight bio-signals against each user's personal baseline.